{{org_field_logo}}
{{org_field_name}}
Registration Number: {{org_field_registration_no}}
PRN Medication Management Policy
1. Purpose and Scope
The purpose of this PRN Medication Management Policy is to provide clear guidelines for the safe, effective, and person-centred management of “as-needed” (PRN) medication within {{org_field_name}}. This policy ensures that PRN medications are administered appropriately, recorded accurately, and monitored effectively to promote the health and well-being of service users.
This policy applies to all staff members involved in the administration, management, and monitoring of PRN medication, including care workers, supervisors, and management. It covers all aspects of PRN medication handling, from prescription to administration and documentation.
2. Policy Statement
{{org_field_name}} is committed to:
- Ensuring that PRN medications are administered safely and effectively.
- Promoting person-centred care by considering individual needs and preferences.
- Adhering to the principles of the Health and Social Care Act 2008, NICE guidelines, and CQC standards.
- Implementing robust systems for documentation, monitoring, and review.
- Supporting staff through comprehensive training and supervision.
We believe that the appropriate use of PRN medication enhances the quality of life for service users while safeguarding their health and well-being.
3. Legal and Regulatory Framework
This policy is implemented in accordance with the following current legislation, regulations and national guidance:
- Health and Social Care Act 2008 and Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, including:
- Regulation 9 – Person-centred care.
- Regulation 11 – Need for consent.
- Regulation 12 – Safe care and treatment.
- Regulation 13 – Safeguarding service users from abuse and improper treatment.
- Regulation 17 – Good governance.
- Regulation 18 – Staffing.
- Regulation 20 – Duty of Candour.
- Human Medicines Regulations 2012, as amended – providing the principal regulatory framework for human medicines.
- Misuse of Drugs Act 1971 and Misuse of Drugs Regulations 2001, as amended – governing controlled drugs, including lawful possession, supply and administration.
- Mental Capacity Act 2005 and current Code of Practice – governing consent, capacity, best-interests decisions and covert administration where a person lacks capacity to make the relevant medicines decision.
- NICE Guideline NG67 – Managing medicines for adults receiving social care in the community.
- Current CQC guidance concerning medicines in adult social care, including guidance on:
- ‘When required’ or PRN medicines.
- Medicines administration records.
- Medicines care plans.
- Training and competency.
- Controlled drugs.
- Covert administration.
- Medicines-related incidents.
PRN medicines must only be supported or administered where the responsibility for medicines support has been assessed, agreed and clearly documented in the service user’s care plan.
4. Definitions
- PRN Medication: “Pro re nata” (Latin for “as needed”) medications prescribed for intermittent use based on individual symptoms, such as pain relief, anxiety management, or nausea control.
- Service User: An individual receiving care and support from {{org_field_name}}.
- MAR Chart: Medication Administration Record used to document medication administration.
- Best Interest Decision: A decision made on behalf of a person who lacks capacity, in line with the Mental Capacity Act 2005.
5. PRN Medication Assessment and Planning
Every service user who requires staff support with PRN medication must have clear, person-centred written guidance available to staff.
The PRN medication plan must be consistent with the prescription, dispensing label, care plan and current medicines record.
For each PRN medicine, the plan must specify, as applicable:
- The name, formulation and strength of the medicine.
- What condition, symptom or circumstance the medicine is prescribed for.
- The prescribed dose.
- The route of administration.
- The minimum interval between doses.
- The maximum dose or maximum number of doses permitted within 24 hours.
- Clear signs, symptoms or circumstances that indicate when the medicine should be offered or administered.
- How the person communicates that they require the medicine.
- Any relevant non-verbal signs or cues where the person may be unable to request the medicine verbally.
- Whether the person requires prompting or staff observation to identify the need.
- What alternative or non-medicine interventions should be considered before the PRN medicine is used, where appropriate.
- What order medicines should be offered where more than one PRN medicine is available for the same condition.
- Expected therapeutic effect.
- Known risks, side effects and monitoring requirements.
- What staff must do if the medicine is ineffective.
- When professional advice must be sought.
- When the PRN medicine should be reviewed.
- What action should be taken where the medicine is being used more frequently than expected or has not been required for a prolonged period.
Where a variable dose has been prescribed, staff must have sufficiently clear written directions to determine the appropriate dose safely.
If the directions are unclear, contradictory or insufficient, staff must not guess. Advice must be obtained from the prescriber, pharmacist or other appropriate healthcare professional.
PRN Medication Outside Scheduled Care Visits
For domiciliary care, the care plan must state how PRN medication needs will be managed outside scheduled care-worker visits.
Where family members or other carers may provide support, the plan must identify:
- Who is responsible.
- How administration will be communicated to care staff.
- How it will be recorded.
- How duplicate doses will be prevented.
Staff must have access to the current PRN plan whenever they are expected to make a decision about offering or administering PRN medication.
PRN Medicines for Distress, Agitation or Behaviour
Where PRN psychotropic medication is prescribed for distress, agitation or behaviour:
- The reason for use must be clearly documented.
- Person-centred preventative and non-medicine approaches must be considered first where appropriate.
- Staff must understand the person’s individual triggers, communication and support plan.
- Medication must not be used merely for staff convenience or as an inappropriate means of controlling behaviour.
- Use must be monitored and reviewed.
- Concerns about frequent, prolonged or inappropriate use must be referred to the prescriber.
- Potential over-medication or inappropriate use must be considered as a possible safeguarding concern.
Where relevant, practice should reflect the principles of STOMP for people with a learning disability and autistic people.
6. Consent and Capacity
6.1. Consent
A person with capacity must be involved in decisions concerning their PRN medication and has the right to accept or decline it.
Staff must:
- Explain the proposed medication support in a way the person can understand.
- Ask whether the person is willing to take the medicine.
- Respect a capacitous refusal.
- Record refusals appropriately.
- Escalate clinically significant refusals in accordance with the PRN plan.
An unwise decision or refusal does not by itself mean that the person lacks capacity.
6.2. Mental Capacity
Where there is reasonable doubt about the person’s capacity to make the particular medication decision, {{org_field_name}} will follow the Mental Capacity Act 2005.
Capacity must be:
- Presumed unless established otherwise.
- Assessed in relation to the specific decision.
- Assessed at the relevant time.
All practicable steps must first be taken to support the person to make their own decision.
Where the person lacks capacity, a lawful best-interests decision must be made by the appropriate decision-maker.
Family members, carers and advocates may be consulted where appropriate, but they do not automatically have legal authority to consent to medication on the person’s behalf.
Where a health and welfare attorney or Court-appointed deputy has relevant authority, that authority will be checked and respected within its lawful limits.
Capacity assessments and best-interests decisions must be clearly documented.
6.3. Covert PRN Administration
PRN medication must not be concealed in food, drink or another substance merely because a person refuses it.
Covert administration may only occur where:
- The person has been assessed as lacking capacity to make the relevant medication decision.
- The medicine is necessary.
- A documented best-interests process has concluded that covert administration is appropriate.
- Less restrictive options have been considered.
- Appropriate prescriber and pharmacy advice has been obtained.
- There is a current, medicine-specific covert administration plan.
The covert plan must record:
- The relevant capacity assessment.
- The best-interests decision.
- Which PRN medicines may be given covertly.
- When each medicine may be used.
- The agreed method of administration.
- Pharmacy or other specialist advice confirming that the proposed method is suitable.
- What staff should do if the person refuses the food or drink containing the medicine.
- Review arrangements.
Covert administration must be recorded clearly on the medicines administration record.
Where capacity fluctuates, a covert administration plan must only be used at a time when the person actually lacks capacity for the relevant decision.
Covert administration arrangements must be reviewed regularly.
7. Safe Administration of PRN Medication
PRN medication must only be administered by staff who are authorised, appropriately trained and assessed as competent.
Before administration, staff must:
- Check the person’s current care plan and PRN medication plan.
- Check the prescription, dispensing label and MAR or electronic medicines record.
- Confirm the service user’s identity.
- Confirm the indication for the PRN medicine.
- Assess whether the person’s current symptoms meet the documented PRN criteria.
- Check whether the person has already received or taken the medicine.
- Check the time of the previous dose.
- Confirm that the minimum interval between doses has passed.
- Check that administration will not exceed the prescribed maximum dose within the relevant period.
- Ask whether the person is ready and willing to take the medicine.
Six Rights of Medicines Administration
Staff must apply the six rights:
- Right person.
- Right medicine.
- Right route.
- Right dose.
- Right time.
- Person’s right to decline.
Accurate documentation remains essential but is not the sixth right.
Following Administration
Staff must:
- Record the medication promptly.
- Record why the PRN medicine was required.
- Record the dose given.
- Record the administration time where relevant.
- Monitor the person’s response.
- Record whether the medicine achieved the intended effect.
- Record adverse effects or other concerns.
- Follow the PRN plan where the medicine is ineffective.
Where the PRN medicine is being required more frequently than expected, appears ineffective, causes adverse effects or is being used in circumstances not covered by the existing plan, staff must escalate this to the appropriate healthcare professional and management.
Staff must not independently change:
- The dose.
- The frequency.
- The minimum interval.
- The maximum daily dose.
- The indication.
- The route of administration.
8. Documentation and Record Keeping
Accurate documentation is essential for safe PRN medication management. Staff must:
- Record administration on the MAR chart immediately.
- Document the reason for administration and the outcome.
- Note any refusals, side effects, or adverse reactions.
The PRN record includes:
- Date, time, and dosage of medication administered.
- Symptom assessment before and after administration.
- Staff initials and signature.
9. Monitoring and Review
PRN medication use is regularly monitored to ensure effectiveness and safety. This includes:
- Daily symptom and medication reviews by care staff.
- Weekly audits by supervisors.
- Monthly reviews involving the service user, family (if appropriate), and healthcare professionals.
Key considerations during review include:
- Frequency of PRN use.
- Effectiveness of medication in managing symptoms.
- Any signs of dependency, misuse, or side effects.
If concerns arise, the care team consults the prescribing healthcare professional for reassessment.
10. Staff Training and Competency
All staff administering PRN medication must:
- Complete accredited medication training.
- Undergo competency assessments during induction and annually.
- Receive ongoing supervision and refresher training.
Training covers:
- PRN medication types, uses, and risks.
- Symptom assessment and decision-making.
- Safe administration, documentation, and reporting.
- Recognising and managing side effects.
11. Storage and Disposal of PRN Medication
PRN medicines belong to the service user and will normally be stored in the person’s own home.
Storage arrangements must reflect:
- The person’s wishes and abilities.
- Manufacturer and dispensing instructions.
- The nature of the medicine.
- The person’s medicines-support assessment.
- Any identified risk of inappropriate or unauthorised access.
- Relevant requirements for refrigeration or other specialist storage.
Storage
PRN medicines should normally:
- Remain in the original packaging or container in which they were supplied.
- Be clearly identifiable.
- Be kept in date.
- Be stored according to the dispensing label and manufacturer’s instructions.
- Be accessible to the person where they manage or participate in managing their own medicines.
PRN medicines do not automatically need to:
- Be stored in a locked cupboard.
- Be separated from regular medicines.
Secure storage will be used where an individual risk assessment identifies that this is necessary.
The care plan must record any agreed storage arrangements.
Controlled Drugs
Where a PRN medicine is a controlled drug:
- Applicable controlled-drug legislation and CQC guidance will be followed.
- Staff administering the medicine must be appropriately trained and assessed as competent.
- Storage will be individually risk-assessed.
In a person’s own home there is no automatic legal requirement:
- To store a controlled drug separately from other medicines.
- To use a controlled-drug cupboard.
- To maintain a separate controlled-drug register solely because the medicine is a controlled drug.
Where the person’s circumstances create a risk of theft, diversion, misuse, accidental access or harm, appropriate secure-storage arrangements will be put in place.
Disposal
Responsibility for returning or disposing of unwanted or expired PRN medicines must be agreed with the person and/or appropriate representative and recorded in the care plan.
Where {{org_field_name}} accepts responsibility:
- The person’s agreement or other lawful authority will be established.
- Appropriate records will be maintained.
- Unwanted medicines will normally be returned to an appropriate pharmacy or otherwise disposed of through an authorised route.
- Controlled drugs and sharps will be managed in accordance with applicable legal and local requirements.
Staff must not dispose of medicines in ordinary household waste, sinks or toilets.
12. Handling Refusals and Errors
Where a person with capacity declines PRN medication:
- Their decision must be respected.
- Staff must not coerce or pressure them.
- The refusal must be documented.
- The person should be monitored where appropriate.
- Staff should consider whether pain, distress, misunderstanding, swallowing difficulty or another factor contributed to the refusal.
- Clinical advice must be obtained where failure to take the medicine may create a significant risk.
Medication Errors and Near Misses
Any PRN medication error or near miss must be reported promptly through {{org_field_name}}’s medicines and incident-reporting arrangements.
Immediate priorities are to:
- Protect the service user from further harm.
- Obtain appropriate clinical advice where necessary.
- Contact emergency services where there is an immediate serious risk.
- Inform the appropriate manager.
- Record what occurred accurately.
- Complete the appropriate MAR entry without falsifying or obscuring the original record.
- Complete an incident report.
- Preserve relevant evidence.
- Review the incident and identify learning.
Examples include:
- Wrong person.
- Wrong PRN medicine.
- Wrong dose.
- Wrong route.
- Administration too soon after a previous dose.
- Exceeding the prescribed maximum dose.
- Omitted PRN medication where it should have been offered.
- Administration without an appropriate indication.
- Administration contrary to the person’s wishes.
- Failure to record administration.
- Duplicate administration.
- Inappropriate use of PRN medication to control behaviour.
Safeguarding
Medication incidents must also be considered under safeguarding procedures.
A medicines-related safeguarding concern may include:
- Deliberately withholding a medicine without valid reason.
- Deliberate misuse of a medicine.
- Use of medication for a purpose other than the person’s benefit.
- Inappropriate use of PRN medication to control behaviour.
- Deliberate over-administration.
- Deliberate harm.
- Repeated unsafe administration indicating neglect or systemic failure.
Where appropriate, the concern will be referred to the local authority safeguarding team in accordance with {{org_field_name}}’s Safeguarding Adults Policy.
Controlled-Drug Incidents
Loss, theft, diversion, discrepancy or other significant incident involving controlled drugs will be escalated in accordance with applicable controlled-drug requirements.
Where appropriate this may include liaison with:
- The relevant NHS England Controlled Drugs Accountable Officer.
- Police.
- CQC.
- Other appropriate agencies.
CQC Notifications
A PRN medication error does not automatically require a CQC statutory notification.
The Registered Manager must assess whether the incident has resulted in a separately notifiable event, including:
- Death.
- Serious injury.
- Abuse or an allegation of abuse.
- An incident reported to or investigated by the police.
Where a statutory notification is required, it must be submitted within the legally required timescale and the medicines error should be identified as a known or possible cause or contributory factor.
Duty of Candour
{{org_field_name}} will act openly and transparently where a medicines-related incident affects a person.
The formal Regulation 20 Duty of Candour procedure will be followed where the incident meets the statutory definition of a notifiable safety incident.
Where the formal threshold is not met, the organisation will nevertheless communicate appropriately with the service user about what happened and any action required.
Learning
All medication errors and relevant near misses will be reviewed to identify:
- Contributory factors.
- Staffing or workload issues.
- Training or competency concerns.
- Deficiencies in PRN plans.
- Record-keeping problems.
- Communication failures.
- Changes required to systems or procedures.
Corrective and preventative actions will be documented and monitored.
13. Communication and Collaboration
Effective communication ensures safe PRN medication management. This includes:
- Regular communication between care staff, service users, families, and healthcare professionals.
- Timely reporting of concerns, side effects, or changes in condition.
- Collaborative decision-making for medication adjustments.
14. Audit and Quality Assurance
We conduct regular audits to ensure adherence to this policy, including:
- Monthly MAR chart audits.
- Random spot checks by supervisors.
- Annual staff competency reviews.
Audit findings inform continuous improvement, ensuring safe, effective PRN medication management.
{{org_field_name}} is committed to the safe, person-centred management of PRN medication. By following this comprehensive policy, we ensure that service users receive appropriate, effective medication while safeguarding their health and well-being. All staff must adhere to this policy and promote best practices in PRN medication management.
15. Policy Review and Updates
This policy will be reviewed at least annually, or sooner where necessary, to ensure that PRN medication arrangements remain safe, person-centred and consistent with current legislation, CQC requirements and NICE guidance.
An earlier review will take place where:
- Human medicines legislation materially changes.
- Controlled-drug legislation or guidance materially changes.
- NICE NG67 is revised or replaced.
- CQC guidance concerning PRN medicines materially changes.
- CQC medicines administration or medicines-record guidance materially changes.
- Mental Capacity Act guidance concerning medicines or covert administration materially changes.
- A serious PRN medication incident occurs.
- Repeated PRN medication errors or near misses are identified.
- Inappropriate or excessive use of PRN medication is identified.
- A safeguarding concern involving PRN medication arises.
- Audits identify deficiencies in PRN plans, MAR records, storage, administration or monitoring.
- New medicines-record systems are introduced.
The Registered Manager will ensure that the review considers:
- PRN medication plans.
- Clear indications for use.
- Minimum dose intervals.
- Maximum daily doses.
- Variable-dose instructions.
- PRN administration outside scheduled visits.
- Refusals.
- Effectiveness monitoring.
- Psychotropic PRN medication.
- Covert administration.
- Controlled drugs.
- Medication incidents and near misses.
- Safeguarding concerns.
- CQC statutory notifications.
- Staff medicines training and competency.
- MAR audits.
- Feedback from service users and relevant representatives.
- Prescriber or pharmacist concerns.
Where weaknesses are identified, {{org_field_name}} will:
- Review the affected person’s PRN medication arrangements.
- Seek appropriate prescriber or pharmacy advice.
- Update care plans and PRN protocols.
- Review staff competency.
- Provide additional training or supervision.
- Review storage and record-keeping arrangements.
- Make safeguarding or statutory notifications where required.
- Implement corrective and preventative action.
Material amendments will be documented, approved and communicated to relevant staff.
Learning from medication incidents, near misses, complaints, safeguarding concerns and audits will be used to continuously improve PRN medication safety.
Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.